Cefuroxime Axetil

Product NDC: 65862-699
11-digit product format: 658620699
Labeler code: 65862
Product ID: 65862-699_5716a24a-653f-488a-bb44-85abffcbf92c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefuroxime Axetil
Dosage form: TABLET
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA065308
Marketing category: ANDA
Marketing start: 2006-03-29
Substance: CEFUROXIME AXETIL
Active strength: 250 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished product	product	65862-699		UNFINISHED	Active or certified unfinished drug listing		2026-08-17
unfinished package	package	65862-699	65862-699-35	UNFINISHED	Active or certified unfinished drug listing		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-699-35	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-699-35	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-699-35	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-699-35	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-699-35	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-699-35	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-699-35	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-699-35	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-699-35	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-699-35	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-699-35	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-699-35	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-699-35	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-699-35	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-699-35	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-699-35	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-699-35	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-699-35	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-699-35	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-699-35	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished product	product		`5b2001dcd8f5…`	`54b53d4dc9e4…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished package	package	65862-699-35	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065308-001	CEFUROXIME AXETIL	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29
A065308-002	CEFUROXIME AXETIL	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29
A065308-003	CEFUROXIME AXETIL	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	RS	2006-03-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A065308-001	AB
A065308-002	AB
A065308-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	RS	2006-03-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	RS	2006-03-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	RS	2006-03-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065308-002	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2006-03-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065308-003	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2006-03-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065308-001	CEFUROXIME AXETIL	EQ 125MG BASE	TABLET / ORAL	AB		2006-03-29	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065308-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065308-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065308-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065308-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065308-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065308-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065308-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065308-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065308-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065308-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065308-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065308-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065308-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065308-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065308-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065308-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065308-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065308-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065308-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065308-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065308-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065308-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065308-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065308-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065308-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065308-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065308-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065308-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065308-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065308-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065308-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065308-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065308-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065308-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065308-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065308-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065308-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065308-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065308-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065308-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefuroxime Axetil
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFUROXIME AXETIL	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
Z49QDT0J8Z	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309095	Internal RxNorm lookup
309097	Internal RxNorm lookup
309098	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
faef39e9-d793-4191-a728-310f6fab759d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ba66f2a7-7ba5-e81a-8863-a38bd5c2e969	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
65862-699-20	Cefuroxime Axetil	20 in 1 BOTTLE	TABLET	20		13
65862-699-60	Cefuroxime Axetil	60 in 1 BOTTLE	TABLET	60		13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-699-20	EA - Each	65862-699	e30d4d4a-0e95-404e-9e2e-d66c8cbdd6a6	1	2014-04-03
65862-699-60	EA - Each	65862-699	07e2d156-ed09-46e0-942d-62c5a383f17d	1	2014-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFUROXIME AXETIL	ACTIVE INGREDIENT	Z49QDT0J8Z	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
CEFUROXIME	ACTIVE MOIETY	O1R9FJ93ED	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
HYDROGENATED COTTONSEED OIL	INACTIVE INGREDIENT	Z82Y2C65EA	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFUROXIME AXETIL (CEFUROXIME AXETIL) TABLET [PD-RX PHARMACEUTICALS, INC.]	9
CEFUROXIME AXETIL	ACTIVE INGREDIENT	Z49QDT0J8Z	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
CEFUROXIME	ACTIVE MOIETY	O1R9FJ93ED	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
HYDROGENATED COTTONSEED OIL	INACTIVE INGREDIENT	Z82Y2C65EA	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	4
CEFUROXIME AXETIL	ACTIVE INGREDIENT	Z49QDT0J8Z	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
CEFUROXIME	ACTIVE MOIETY	O1R9FJ93ED	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
HYDROGENATED COTTONSEED OIL	INACTIVE INGREDIENT	Z82Y2C65EA	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEFUROXIME AXETIL TABLET [DIRECT RX]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFUROXIME AXETIL TABLET [DIRECT RX]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-699	CEFUROXIME AXETIL TABLET [AUROBINDO PHARMA LIMITED]	13	Current NDC, Legacy NDC, 2 package rows	20240501_faef39e9-d793-4191-a728-310f6fab759d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 17 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefuroxime Axetil	CEFUROXIME AXETIL	REMEDYREPACK INC.	76cec54f-d167-4298-951b-5411a3c47f4a	2026-08-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	Redpharm Drug	56cb6f42-9ae1-38e7-e063-6294a90a3feb	2026-07-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	85cdd8d9-557e-4d15-855a-027e7809cf64	2026-05-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	d14d4184-3e29-43cd-8046-658699c70f03	2026-05-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	PD-Rx Pharmaceuticals, Inc.	a84ac4ed-c268-4e9f-9df8-256e0a64cd16	2026-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	a940ba01-2b53-4947-9019-d3d8f4e9ad80	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	aa6685c1-51ed-466a-ae7f-89a82986a7b1	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	119c4d09-2324-498f-9318-1f8db49ad4b6	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	NuCare Pharmaceuticals, Inc.	3f92c452-18b4-5af8-e063-6394a90aaa53	2025-09-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	Preferred Pharmaceuticals Inc.	bc9200d2-4a6d-4847-ba85-8e9d378390de	2025-07-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	Coupler LLC	2c619a79-6b69-b9fa-e063-6394a90a8f27	2025-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	Coupler LLC	2c3a502f-8e72-c4d2-e063-6394a90a6fa5	2025-01-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	NorthStar Rx LLC	fd79c41e-b0e9-47dc-a3ce-caacdc66bc96	2024-04-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	Aurobindo Pharma Limited	faef39e9-d793-4191-a728-310f6fab759d	2024-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308 ndc (product): 65862-699
Cefuroxime Axetil	CEFUROXIME AXETIL	Rising Pharma Holdings, Inc.	66f8d37f-aebc-4435-af80-dfd7b3770088	2024-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	eb180b38-f8c8-4dbf-856a-347d3ebac857	2024-02-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308
Cefuroxime Axetil	CEFUROXIME AXETIL	A-S Medication Solutions	bcf7870a-7e45-4ae1-a9b4-457e4781886a	2024-01-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065308 application number: ANDA065308

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
Z49QDT0J8Z	CEFUROXIME AXETIL	64544-07-6	CEFUROXIME AXETIL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	a84ac4ed-c268-4e9f-9df8-256e0a64cd16	21
309097	cefuroxime 250 MG Oral Tablet	SCD	a84ac4ed-c268-4e9f-9df8-256e0a64cd16	21
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	a84ac4ed-c268-4e9f-9df8-256e0a64cd16	21
309095	cefuroxime axetil 125 MG Oral Tablet	PSN	faef39e9-d793-4191-a728-310f6fab759d	13
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	faef39e9-d793-4191-a728-310f6fab759d	13
309098	cefuroxime axetil 500 MG Oral Tablet	PSN	faef39e9-d793-4191-a728-310f6fab759d	13
309095	cefuroxime 125 MG Oral Tablet	SCD	faef39e9-d793-4191-a728-310f6fab759d	13
309097	cefuroxime 250 MG Oral Tablet	SCD	faef39e9-d793-4191-a728-310f6fab759d	13
309098	cefuroxime 500 MG Oral Tablet	SCD	faef39e9-d793-4191-a728-310f6fab759d	13
309095	cefuroxime (as cefuroxime axetil) 125 MG Oral Tablet	SY	faef39e9-d793-4191-a728-310f6fab759d	13
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	faef39e9-d793-4191-a728-310f6fab759d	13
309098	cefuroxime (as cefuroxime axetil) 500 MG Oral Tablet	SY	faef39e9-d793-4191-a728-310f6fab759d	13
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	a940ba01-2b53-4947-9019-d3d8f4e9ad80	6
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	119c4d09-2324-498f-9318-1f8db49ad4b6	6
309097	cefuroxime 250 MG Oral Tablet	SCD	a940ba01-2b53-4947-9019-d3d8f4e9ad80	6
309097	cefuroxime 250 MG Oral Tablet	SCD	119c4d09-2324-498f-9318-1f8db49ad4b6	6
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	119c4d09-2324-498f-9318-1f8db49ad4b6	6
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	a940ba01-2b53-4947-9019-d3d8f4e9ad80	6
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	d14d4184-3e29-43cd-8046-658699c70f03	3
309097	cefuroxime 250 MG Oral Tablet	SCD	d14d4184-3e29-43cd-8046-658699c70f03	3
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	d14d4184-3e29-43cd-8046-658699c70f03	3
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	ad1a2f81-2595-47eb-9c2e-967c4b8e26bd	2
309097	cefuroxime 250 MG Oral Tablet	SCD	ad1a2f81-2595-47eb-9c2e-967c4b8e26bd	2
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	ad1a2f81-2595-47eb-9c2e-967c4b8e26bd	2
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	2c619a79-6b69-b9fa-e063-6394a90a8f27	1
309097	cefuroxime 250 MG Oral Tablet	SCD	2c619a79-6b69-b9fa-e063-6394a90a8f27	1
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	2c619a79-6b69-b9fa-e063-6394a90a8f27	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-699-20	65862069920	20 TABLET in 1 BOTTLE (65862-699-20)	20 tablet	2006-03-29	0000-00-00	No	No	Current
65862-699-35	65862069935	3500 TABLET in 1 BAG (65862-699-35)	3500 tablet	29-MAR-06				Current
65862-699-60	65862069960	60 TABLET in 1 BOTTLE (65862-699-60)	60 tablet	2006-03-29	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefuroxime Axetil	A-S Medication Solutions	2026-05-14	Human Prescription Drug Label	3
Cefuroxime Axetil	PD-Rx Pharmaceuticals, Inc.	2026-03-18	HUMAN PRESCRIPTION DRUG LABEL	21
Cefuroxime Axetil	A-S Medication Solutions	2026-01-23	Human Prescription Drug Label	6
Cefuroxime Axetil	A-S Medication Solutions	2025-10-08	Human Prescription Drug Label	6
Cefuroxime Axetil	Coupler LLC	2025-01-23	HUMAN PRESCRIPTION DRUG LABEL	1
Cefuroxime Axetil	Aurobindo Pharma Limited	2024-04-29	Human Prescription Drug Label	13
Cefuroxime Axetil	NuCare Pharmaceuticals, Inc. \| NuCarePharmaceuticals, Inc.	2017-06-16	HUMAN PRESCRIPTION DRUG LABEL	1
CEFUROXIME AXETIL	DIRECT RX	2015-11-03	HUMAN PRESCRIPTION DRUG LABEL	2